58 results
424B3
BIAF
bioAffinity Technologies, Inc.
23 Sep 24
Prospectus supplement
4:00pm
and materials. We had previously been granted a license from Village Oaks to use its intellectual property, pursuant to a joint development and project … materials manufactured in compliance with standards imposed by the CMS, FDA, and foreign regulators.
Moreover, as we develop our diagnostic tests
D
BIAF
bioAffinity Technologies, Inc.
12 Aug 24
$1.30 mm in equity / options / securities to be acquired, sold $1.30 mm, 3 investors
4:00pm
to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials under this undertaking or otherwise … and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
D
xh7le7jub dw4xd2
12 Aug 24
$450.00 k in equity / options / securities to be acquired, sold $450.00 k, 3 investors
4:00pm
8-K
EX-1.1
c48bda99emqal
5 Aug 24
Entry into a Material Definitive Agreement
9:03am
8-K
EX-10.1
ri2mbf8 z0p7
5 Aug 24
Entry into a Material Definitive Agreement
9:03am
424B5
hw287m8mw5afn9m1j
5 Aug 24
Prospectus supplement for primary offering
9:00am
424B3
t4lkekk7a f63p1562a
16 Apr 24
Prospectus supplement
7:19pm
DEFA14A
2rr4m85 hsvu
15 Apr 24
Additional proxy soliciting materials
6:17am
POS AM
vef3g 60vg8d79n7chf
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
8-K
EX-99.1
ow9p14tmxxzu45e upr
1 Apr 24
Results of Operations and Financial Condition
4:00pm
D
6brtjrq 7cwutc6bwz6o
20 Mar 24
$2.62 mm in equity / options / securities to be acquired, sold $2.62 mm, 3 investors
2:24pm
8-K
EX-1.1
twrp26age 4jb7
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm